These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Beta-blockers in cirrhosis: thank you for your attention. Ge PS; Runyon BA J Hepatol; 2014 Aug; 61(2):451-2. PubMed ID: 24792969 [No Abstract] [Full Text] [Related]
4. Beta-blockers in cirrhosis: therapeutic window or an aspirin for all? Ferrarese A; Tsochatzis E; Burroughs AK; Senzolo M J Hepatol; 2014 Aug; 61(2):449-50. PubMed ID: 24768827 [No Abstract] [Full Text] [Related]
5. Continued controversy over the safety of beta-blockers in decompensated cirrhosis. Albillos A; Martínez J; Téllez L Hepatology; 2016 May; 63(5):1726-9. PubMed ID: 26474289 [No Abstract] [Full Text] [Related]
6. An apology for beta blockers. Thalheimer U; Bosch J; Burroughs AK J Hepatol; 2014 Aug; 61(2):450-1. PubMed ID: 24768757 [No Abstract] [Full Text] [Related]
7. The changing role of beta-blocker therapy in patients with cirrhosis. Ge PS; Runyon BA J Hepatol; 2014 Mar; 60(3):643-53. PubMed ID: 24076364 [TBL] [Abstract][Full Text] [Related]
8. Beta blockers in cirrhosis: The window re-opens. Garcia-Tsao G J Hepatol; 2016 Mar; 64(3):532-4. PubMed ID: 26724557 [No Abstract] [Full Text] [Related]
9. Prophylaxis with beta blockers as a performance measure of quality health care in cirrhosis. Talwalkar JA Gastroenterology; 2006 Mar; 130(3):1005-7. PubMed ID: 16530542 [No Abstract] [Full Text] [Related]
10. Quantitative and qualitative analysis of platelet GPIb and von Willebrand factor in liver cirrhosis. Beer JH; Clerici N; Baillod P; von Felten A; Schlappritzi E; Büchi L Thromb Haemost; 1995 Apr; 73(4):601-9. PubMed ID: 7495066 [TBL] [Abstract][Full Text] [Related]
11. Effects of beta-blockers on survival for patients with cirrhosis and refractory ascites. Lo GH Hepatology; 2011 Mar; 53(3):1068-9. PubMed ID: 21374686 [No Abstract] [Full Text] [Related]
12. Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections. Galbois A; Das V; Thabut D; Maury E; Ait-Oufella H; Housset C; Guidet B Hepatology; 2011 Apr; 53(4):1412-3. PubMed ID: 21480358 [No Abstract] [Full Text] [Related]
13. Is this really the end of beta-blockers in patients with cirrhosis and refractory ascites? Thevenot T; Cervoni JP; Monnet E; Sheppard F; Martino VD Hepatology; 2011 Feb; 53(2):715-6. PubMed ID: 20814893 [No Abstract] [Full Text] [Related]
14. NONSELECTIVE BETA-BLOCKERS IN PATIENTS WITH CIRRHOSIS: "THE THERAPEUTIC WINDOW". Dimache M; Gîrleanu I; Carpov E; Trifan A; Stanciu C Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):23-8. PubMed ID: 27125068 [TBL] [Abstract][Full Text] [Related]
15. Reply: On the use of nonselective beta blockers in cirrhosis. Garcia-Tsao G; Kaplan DE Hepatology; 2024 Aug; 80(2):E35. PubMed ID: 38626347 [No Abstract] [Full Text] [Related]
16. Letter to the Editor: On the use of nonselective beta-blockers in cirrhosis. Przybyszewski EM; Bhan I; Yarze JC Hepatology; 2024 Aug; 80(2):E33-E34. PubMed ID: 38626348 [No Abstract] [Full Text] [Related]
17. Empiric beta-blockers for the prophylaxis of variceal hemorrhage: cost effective or clinically applicable? Rubenstein JH; Inadomi JM Hepatology; 2003 Feb; 37(2):249-52. PubMed ID: 12540773 [No Abstract] [Full Text] [Related]
19. Commentary: non-haemodynamic effects of beta-blockers in cirrhosis--more than meets the eye? Sharma S; Feld JJ Aliment Pharmacol Ther; 2013 Sep; 38(6):652. PubMed ID: 23964732 [No Abstract] [Full Text] [Related]
20. Bacterial translocation and nonselective β-blockers in portal hypertension: where we are, what we still need. La Mura V; Colombo M Gastroenterology; 2014 Jul; 147(1):247-9. PubMed ID: 24866430 [No Abstract] [Full Text] [Related] [Next] [New Search]